Anirudha Bartake
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anirudha Bartake has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Sangeeta Palaskar
Department of Oral Pathology and Microbiology, Sinhgad Dental College and Hospital, Pune, Maharashtra, India
4 shared publications Bindiya Narang
Department of Oral Pathology and Microbiology, Sinhgad Dental College and Hospital, Pune, Maharashtra, India
3 shared publications- Bindiya Narang
Sinhgad Dental College and Hospital
2 shared publications Gargi Sarode
Department of Oral Pathology and Microbiology, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India
2 shared publicationsSupriya Koshti
Professor, Department of Oral and Maxillofacial Pathology, Sinhgad Dental College and Hospital, Pune Maharashtra, India
2 shared publicationsAmit Girme
Department of Surgery, Dr. DY Patil Medical College & Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India
1 shared publication
Latest Publications
- Open Access
- 1 April 2024
- Published by Medknow in Journal of Oral and Maxillofacial Pathology
- Vol. 28 (2) , 186-191
Immunohistochemical analysis of p53 and p63 in selected odontogenic cysts and tumours
Background: It is a well-recognized fact that abnormal cell proliferation plays a crucial role in the development of odontogenic lesions. p53 is a tumour-suppressor gene which assists in cell cycle regulation and p63 is a homolog of p53 responsible for ectodermal differentiation and maintenance of stratified epithelial progenitor-cell. Analysing the tissue expression of p53 and p63 in odontogenic lesions may provide us with an insight into their potential role in the development of these lesions. Objective: The objective is to study the expression of p53 and p63 in selected odontogenic lesions using immunohistochemistry. Materials and Methods: Formalin-fixed paraffin-embedded tissues of 15 ameloblastomas, 10 adenomatoid odontogenic tumours (AOT), 15 odontogenic keratocysts (OKCs), 10 dentigerous cysts (DCs) along with 10 cases of normal mucosa were retrieved from the departmental archives. These specimens were then subjected to immunohistochemical staining using p53 and p63 oncoproteins. Results: p53 and p63 immune-expression showed mainly intranuclear localization. The mean positivity of p53 in ameloblastoma (59.45%) and OKC (26.38%) was significantly higher than AOT (6.77%) and DC (4%). In contrast, there was no significant difference in the positivity of p63 in between ameloblastoma (77.55%), AOT (69.50%), OKC (76.47%), and DC (50.69%). Conclusion: p53 expression can be correlated with the clinical behaviour of the odontogenic lesions and it can be used as a prognostic marker in odontogenic cysts and tumours. In contrast, p63 expression does not corelate with the biological behaviour of odontogenic lesions.
- 1 April 2024
- Published by Medknow in Journal of Oral and Maxillofacial Pathology
- Vol. 28 (2) , 186-191
Open AccessImmunohistochemical analysis of p53 and p63 in selected odontogenic cysts and tumours
Background: It is a well-recognized fact that abnormal cell proliferation plays a crucial role in the development of odontogenic lesions. p53 is a tumour-suppressor gene which assists in cell cycle regulation and p63 is a homolog of p53 responsible for ectodermal differentiation and maintenance of stratified epithelial progenitor-cell. Analysing the tissue expression of p53 and p63 in odontogenic lesions may provide us with an insight into their potential role in the development of these lesions. Objective: The objective is to study the expression of p53 and p63 in selected odontogenic lesions using immunohistochemistry. Materials and Methods: Formalin-fixed paraffin-embedded tissues of 15 ameloblastomas, 10 adenomatoid odontogenic tumours (AOT), 15 odontogenic keratocysts (OKCs), 10 dentigerous cysts (DCs) along with 10 cases of normal mucosa were retrieved from the departmental archives. These specimens were then subjected to immunohistochemical staining using p53 and p63 oncoproteins. Results: p53 and p63 immune-expression showed mainly intranuclear localization. The mean positivity of p53 in ameloblastoma (59.45%) and OKC (26.38%) was significantly higher than AOT (6.77%) and DC (4%). In contrast, there was no significant difference in the positivity of p63 in between ameloblastoma (77.55%), AOT (69.50%), OKC (76.47%), and DC (50.69%). Conclusion: p53 expression can be correlated with the clinical behaviour of the odontogenic lesions and it can be used as a prognostic marker in odontogenic cysts and tumours. In contrast, p63 expression does not corelate with the biological behaviour of odontogenic lesions.
- Open Access
- 15 February 2024
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 14 (2) , 169-174
Evaluation of CYP1B1, oxidative stress and phase II detoxification enzyme status in oral cancer progression model
- 15 February 2024
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 14 (2) , 169-174
Open AccessEvaluation of CYP1B1, oxidative stress and phase II detoxification enzyme status in oral cancer progression model
- Open Access
- 1 April 2022
- Published by Jaypee Brothers Medical Publishing in Dental Journal of Advance Studies
- Vol. 10 (01) , 046-050
Evaluation of Midkine Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: A Cross-Sectional Study
Introduction Oral cancer accounts for 3% of all malignancies diagnosed worldwide annually. Midkine (MK) plays a role in oncogenesis and tumor progression, including cell migration, mitogenesis, antiapoptosis, and angiogenesis. Aim and Objective To study and compare MK expression in various grades of oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC). Methodology This is a cross-sectional study where 60 archival specimens of OSCC, OED, and control were taken for immunohistochemical examination. Antibody MK (A-9) SC-46701 mouse monoclonal (200µg/mL, Santacruze Biotechnology) was used for immunohistochemical staining. The stained sections were observed under the objective (100 × ) of research microscope (DM 1000 LED) with computer-assisted image analyzer (Leica Application Suit V-4.1). Quantitative analysis was done to count MK reactive cells in all groups. Statistical analysis was performed using Kruskal–Wallis H test with posthoc Bonferroni's test for multiple group comparisons, and p-value < 0.05 was considered as statistically significant. Results MK expression was observed in OSCC and OED and was absent in control. The distribution of average percentage positivity was significantly higher in OED compared with OSCC and control. Statistically significant correlation was found between the size of the tumor and increased MK expression. Conclusion MK protein is overexpressed in OED and OSCC, and can be used as biological marker for early detection.
- 1 April 2022
- Published by Jaypee Brothers Medical Publishing in Dental Journal of Advance Studies
- Vol. 10 (01) , 046-050
Open AccessEvaluation of Midkine Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: A Cross-Sectional Study
Introduction Oral cancer accounts for 3% of all malignancies diagnosed worldwide annually. Midkine (MK) plays a role in oncogenesis and tumor progression, including cell migration, mitogenesis, antiapoptosis, and angiogenesis. Aim and Objective To study and compare MK expression in various grades of oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC). Methodology This is a cross-sectional study where 60 archival specimens of OSCC, OED, and control were taken for immunohistochemical examination. Antibody MK (A-9) SC-46701 mouse monoclonal (200µg/mL, Santacruze Biotechnology) was used for immunohistochemical staining. The stained sections were observed under the objective (100 × ) of research microscope (DM 1000 LED) with computer-assisted image analyzer (Leica Application Suit V-4.1). Quantitative analysis was done to count MK reactive cells in all groups. Statistical analysis was performed using Kruskal–Wallis H test with posthoc Bonferroni's test for multiple group comparisons, and p-value < 0.05 was considered as statistically significant. Results MK expression was observed in OSCC and OED and was absent in control. The distribution of average percentage positivity was significantly higher in OED compared with OSCC and control. Statistically significant correlation was found between the size of the tumor and increased MK expression. Conclusion MK protein is overexpressed in OED and OSCC, and can be used as biological marker for early detection.
- 4 March 2017
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 33 (2) , 213-214
Nerve sheath myxoma of the oral cavity: a distinct entity
Nerve sheath myxomas (NSM) are uncommon benign tumours of nerve sheath origin. These tumours are most often located in the dermis and subcutaneous tissue of the head and neck region, but less frequently can also involve extracutaneous sites but they are rarely seen in the oral cavity. Many authors consider nerve sheath myxoma and neurothekeoma to be variants of the same tumour, though currently it has been demonstrated that both the lesions are distinct entities with different origins and unique morphological features. Herein we report a case of Nerve Sheath Myxoma on the palatal gingiva.
- 4 March 2017
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 33 (2) , 213-214
Nerve sheath myxoma of the oral cavity: a distinct entity
Nerve sheath myxomas (NSM) are uncommon benign tumours of nerve sheath origin. These tumours are most often located in the dermis and subcutaneous tissue of the head and neck region, but less frequently can also involve extracutaneous sites but they are rarely seen in the oral cavity. Many authors consider nerve sheath myxoma and neurothekeoma to be variants of the same tumour, though currently it has been demonstrated that both the lesions are distinct entities with different origins and unique morphological features. Herein we report a case of Nerve Sheath Myxoma on the palatal gingiva.
- Open Access
- 1 January 2014
- Published by Medknow in Journal of Oral and Maxillofacial Pathology
- Vol. 18 (3) , 469-71
Teratoid cyst of the oral cavity: A rare entity
The teratoid cyst is a rare variant of the dermoid cyst which seldom occurs in the oral cavity. If seen, they generally present as slow growing cysts of the floor of mouth, reported commonly in the 2 nd and 3 rd decade of life in males. Histopathologically, dermoid cyst is classified as epidermoid cyst, true dermoid cyst and teratoid cyst depending on the presence of adnexal structures and derivatives of all three germ layers. Herewith we report a rare case of teratoid cyst of the floor of the mouth, in a 2-year-old female child, which was present since birth.
- 1 January 2014
- Published by Medknow in Journal of Oral and Maxillofacial Pathology
- Vol. 18 (3) , 469-71
Open AccessTeratoid cyst of the oral cavity: A rare entity
The teratoid cyst is a rare variant of the dermoid cyst which seldom occurs in the oral cavity. If seen, they generally present as slow growing cysts of the floor of mouth, reported commonly in the 2 nd and 3 rd decade of life in males. Histopathologically, dermoid cyst is classified as epidermoid cyst, true dermoid cyst and teratoid cyst depending on the presence of adnexal structures and derivatives of all three germ layers. Herewith we report a rare case of teratoid cyst of the floor of the mouth, in a 2-year-old female child, which was present since birth.
- Open Access
- 1 January 2013
- Published by Medknow in Journal of Dental and Allied Sciences
- Vol. 2 (2) , 74
Basaloid Squamous Cell Carcinoma Involving the Alveolar Ridge, Buccal & Lingual Vestibule - A Case Report
J Dent Allied Sci, Official publication of Sinhgad Dental College & Hospital
- 1 January 2013
- Published by Medknow in Journal of Dental and Allied Sciences
- Vol. 2 (2) , 74
Open AccessBasaloid Squamous Cell Carcinoma Involving the Alveolar Ridge, Buccal & Lingual Vestibule - A Case Report
J Dent Allied Sci, Official publication of Sinhgad Dental College & Hospital
- Open Access
- 1 January 2011
- Published by Medknow in Contemporary Clinical Dentistry
- Vol. 2 (4) , 274-7
Inflammatory myofibroblastic tumor
Inflammatory myofibroblastic tumor is an uncommon lesion of unknown cause. It encompasses a spectrum of myofibroblastic proliferation along with varying amount of inflammatory infiltrate. A number of terms have been applied to the lesion, namely, inflammatory pseudotumor, fibrous xanthoma, plasma cell granuloma, pseudosarcoma, lymphoid hamartoma, myxoid hamartoma, inflammatory myofibrohistiocytic proliferation, benign myofibroblatoma, and most recently, inflammatory myofibroblastic tumor. The diverse nomenclature is mostly descriptive and reflects the uncertainty regarding true biologic nature of these lesions. Recently, the concept of this lesion being reactive has been challenged based on the clinical demonstration of recurrences and metastasis and cytogenetic evidence of acquired clonal chromosomal abnormalities. We hereby report a case of inflammatory pseudotumor and review its inflammatory versus neoplastic behavior.
- 1 January 2011
- Published by Medknow in Contemporary Clinical Dentistry
- Vol. 2 (4) , 274-7
Open AccessInflammatory myofibroblastic tumor
Inflammatory myofibroblastic tumor is an uncommon lesion of unknown cause. It encompasses a spectrum of myofibroblastic proliferation along with varying amount of inflammatory infiltrate. A number of terms have been applied to the lesion, namely, inflammatory pseudotumor, fibrous xanthoma, plasma cell granuloma, pseudosarcoma, lymphoid hamartoma, myxoid hamartoma, inflammatory myofibrohistiocytic proliferation, benign myofibroblatoma, and most recently, inflammatory myofibroblastic tumor. The diverse nomenclature is mostly descriptive and reflects the uncertainty regarding true biologic nature of these lesions. Recently, the concept of this lesion being reactive has been challenged based on the clinical demonstration of recurrences and metastasis and cytogenetic evidence of acquired clonal chromosomal abnormalities. We hereby report a case of inflammatory pseudotumor and review its inflammatory versus neoplastic behavior.
- 31 December 2009
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 47 (8) , 638-640
Two adenomatoid odontogenic tumours of the maxilla: A case report
- 31 December 2009
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 47 (8) , 638-640
Two adenomatoid odontogenic tumours of the maxilla: A case report